Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Instituto de Salud Carlos III | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The goal of this study is to evaluate the effects of nutritional supplementation and physical activity interventions on recovery, muscle strength, nutritional status, inflammation, and metabolic health in adults with colon cancer undergoing surgery.
Patients with colon cancer frequently experience loss of muscle mass, reduced physical function, and nutritional deterioration both before and after surgery, which may adversely affect recovery and quality of life.
A key objective of this study is to assess whether a postoperative intervention combining nutritional supplementation with beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, together with a structured physical activity program, can improve muscle strength and functional recovery following colon cancer surgery.
This study aims to answer the following questions:
Participants will be adults diagnosed with colon cancer who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Patients will be recruited prior to surgery and will enter a prehabilitation phase integrated into routine care provided by the Endocrinology and Nutrition Department.
During this prehabilitation phase, nutritional status will be assessed and optimized using standard clinical care, including oral nutritional supplementation when indicated. The aim is to improve the patient's condition before surgery. Approximately one month after surgery, once initial postoperative recovery has been completed, participants will enter the intervention and assessment phase (baseline visit).
Participants will then be randomly assigned to one of four study groups in a 2×2 factorial design. These groups combine two nutritional strategies (standard care or supplementation with HMB and vitamin D) and two physical activity approaches (supervised exercise or general activity recommendations). The physical activity component, supervised by the Endocrinology and Nutrition team, will be objectively evaluated using an accelerometer-based device. Participants will be followed for approximately six months, with assessments at about 3 and 6 months after the baseline visit.
At each visit, participants will undergo:
The results of this study will contribute to a more profound understanding of how tailored nutritional strategies and postoperative physical activity may support recovery and functional health in patients undergoing surgery for colon cancer.
Colon cancer patients frequently present with nutritional impairment, systemic inflammation, and early loss of muscle mass even before surgical treatment. These conditions may be exacerbated by surgical stress, reduced intake, and postoperative physical inactivity, leading to delayed recovery, functional decline, and impaired quality of life. Interventions targeting nutritional and functional status across the perioperative period may help improve physiological reserve and support postoperative recovery.
The NIMA study (Nutritional, Inflammatory, and Muscular Assessment) is designed to evaluate the impact of perioperative nutritional care and postoperative physical activity strategies on recovery, muscle strength, nutritional status, inflammation, metabolic health, and gut microbiota in adults undergoing surgery for colon cancer. The study combines routine preoperative nutritional management with a structured postoperative intervention and follow-up period, allowing assessment of short- and medium-term changes during recovery.
Study Setting and Population: This study includes adult patients diagnosed with colon cancer stages I to III, (TNM classification) who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Participants are identified and recruited before surgery through standard clinical pathways. All participants provide written informed consent before enrollment. The study is conducted in accordance with ethical principles and has been approved by the appropriate ethics committee.
Prehabilitation Phase (Preoperative Nutritional Care): Approximately two weeks before surgery, patients undergo a prehabilitation phase integrated into routine clinical care provided by the Endocrinology and Nutrition Department. This phase includes assessment and optimization of nutritional status through clinical evaluation, follow-up, and oral hypercaloric and hyperproteic supplementation when indicated. The aim is to improve metabolic condition and physiological reserve prior to surgical stress.
Surgical Treatment and Standard Postoperative Care: All participants undergo standard surgical treatment and postoperative oncological management according to institutional clinical practice. Participation in the study does not modify surgical procedures, immediate postoperative care, or oncological treatment.
Postoperative Interventions(Factorial Design): Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention phase (baseline visit). Participants are randomly assigned to one of four study groups according to a 2×2 factorial design:
The supervised physical activity program consists of structured, progressive resistance and functional exercises adapted to each participant's postoperative condition, targeting major muscle groups to improve muscle strength and functional capacity. Participants assigned to general physical activity receive standard recommendations according to routine clinical practice. Physical activity levels are objectively assessed using a wearable accelerometer.
Follow-up and Assessments: Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention and assessment phase (baseline visit) and are followed for approximately six months, with follow-up assessments at around 3 and 6 months. A comprehensive morphofunctional evaluation is performed at baseline and repeated at 6 months, including body composition, muscle strength, functional performance, and nutritional assessment using techniques such as bioelectrical impedance analysis, nutritional ultrasound, and standardized functional tests. Additional strength and resistance tests are also conducted as part of the study-specific evaluations. Biological samples (blood, urine, and stool) are collected at predefined time points to assess metabolic, inflammatory, and microbiota-related parameters. At the 3-month visit, a partial assessment is carried out, including selected clinical, functional, and questionnaire-based measures(including validated questionnaires assessing health status, quality of life, dietary intake, physical activity levels, and psychological well-being), allowing evaluation of both short- and medium-term changes during postoperative recovery. For participants assigned to the structured and supervised physical activity program, physical activity adherence, intensity, and patterns are objectively monitored using a wearable accelerometer, which is worn for 7 consecutive days monthly throughout the follow-up period, providing quantitative data on real-world physical activity behavior.
Study Relevance: By integrating perioperative nutritional care with structured postoperative interventions within a factorial design, the NIMA study aims to determine the independent and combined effects of nutritional supplementation and physical activity on recovery. The findings may contribute to optimizing perioperative care and improving functional outcomes in patients undergoing colon cancer surgery.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard nutritional care + supervised exercise program | Experimental | Participants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. |
|
| Enhanced nutritional supplementation + non-structured physical activity | Experimental | Participants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. |
|
| Enhanced Nutritional Supplementation + Supervised Physical Activity | Experimental | Participants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Standard hypercaloric-hyperproteic nutritional supplementation | Dietary Supplement | Participants receive a standard oral nutritional supplementation consisting of a hypercaloric and hyperproteic formula designed to support recovery and nutritional status in patients undergoing surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in phase angle (PhA) | Phase angle will be assessed by bioelectrical impedance analysis (BIA) as a bioelectrical marker of nutritional and cellular status. Results will be expressed in degrees. | Baseline (first postoperative visit) and 6 months follow-up |
| Change in quadriceps rectus femoris cross-sectional area | Muscle mass will be assessed using nutritional ultrasound by measuring the cross-sectional area of the quadriceps rectus femoris at a standardized anatomical site (cm²). | Baseline (first postoperative visit) and 6 months follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma concentration of inflammatory and metabolic biomarkers measured by multiplex immunoassay | Plasma concentrations of selected biomarkers (including adiponectin, FABP-3, FGF-21, BDNF, IL-6, IL-15, TNF-α, and MCP-1) will be measured using multiplex immunoassay technology (Bio-Plex MAGPIX / Luminex xMAP). Each biomarker will be analyzed as an individual continuous variable and expressed in pg/mL. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Manuel Macías-González, PhD. | Contact | +34 952 36 76 00 | mmacias.manuel@gmail.com | |
| Libia Alejandra Garcia-Flores, PhD. | Contact | +34 952 36 76 00 | libia.garcia@ibima.eu |
| Name | Affiliation | Role |
|---|---|---|
| Manuel Macías-Gonzalez, PhD | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS) | Principal Investigator |
| Carolina Muriel-Lopez, PhD | Hospital Regional de Malaga | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario Virgen de la Victoria | Recruiting | Málaga | Malaga | 29010 | Spain |
A decision regarding the sharing of individual participant data (IPD) has not yet been made. The study has received a favorable opinion from the relevant Research Ethics Committee. As described in the participant information and informed consent, data collected in this study are handled under strict confidentiality and in accordance with applicable data protection regulations, and are intended for research purposes within the scope of the project. If IPD is shared in the future, this would occur only in a de-identified format and upon reasonable request for scientific purposes.
Not provided
Not provided
Not provided
Not provided
Not provided
Participants are assigned to one of four parallel study groups representing different combinations of nutritional supplementation and physical activity interventions during the postoperative period.
Not provided
Not provided
Due to the nature of the interventions, participants and care providers are not blinded. Data analysis will be performed using coded group allocation.
Not provided
| Standard nutritional care + general physical activity recommendations | Active Comparator | Participants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. |
|
|
|
| HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium | Dietary Supplement | Participants receive an oral hypercaloric and hyperproteic nutritional supplementation enriched with β-hydroxy β-methylbutyrate (HMB) and supplemented with vitamin D and calcium. This formulation is designed to support muscle mass preservation and functional recovery in patients undergoing surgical treatment. |
|
|
| Supervised exercise program | Behavioral | Participants follow a structured and supervised physical activity program including resistance exercises and functional training. Physical activity levels are periodically monitored using wearable activity devices. |
|
|
| General physical activity recommendations | Behavioral | Participants receive general recommendations for physical activity according to routine clinical practice but do not participate in the structured supervised exercise program. |
|
|
| From baseline (first postoperative visit), 3 months and 6 months follow-up |
| Percentage of DNA methylation in peripheral blood mononuclear cells (PBMCs)by quantitative PCR | DNA methylation levels will be assessed in peripheral blood mononuclear cells (PBMCs) using bisulfite conversion followed by quantitative PCR. Results will be expressed as the percentage of methylated cytosines at CpG sites. | Baseline (first postoperative visit) and 6 months follow-up |
| Change in urinary oxylipin concentrations by UHPLC-MS/MS | Selected oxylipins, including isoprostanes, prostaglandins, and thromboxane, will be quantified in first-morning urine samples using targeted ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-QqQ-MS/MS). Results will be expressed as concentrations normalized to urinary creatinine (e.g., ng/mg creatinine). | Baseline (first postoperative visit) and 6 months follow-up |
| Change in relative abundance of gut microbiota taxa | Gut microbiota composition will be assessed in stool samples using 16S rRNA gene sequencing. Relative abundance of bacterial taxa will be quantified at different taxonomic levels (e.g., phylum, genus) and expressed as percentages (%) of total sequencing reads per sample. | Baseline (first postoperative visit) and 6 months follow-up |
| Change in health-related quality of life score (EORTC QLQ-C30) | Health-related quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Scores will be calculated according to standard scoring procedures and expressed on a scale from 0 to 100. | Baseline (first postoperative visit), 3 months, and 6 months follow-up |
| ID | Term |
|---|---|
| D003110 | Colonic Neoplasms |
| D009043 | Motor Activity |
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D001519 | Behavior |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D014807 | Vitamin D |
| D002118 | Calcium |
| ID | Term |
|---|---|
| D012632 | Secosteroids |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D008673 | Metals, Alkaline Earth |
| D004602 | Elements |
| D007287 | Inorganic Chemicals |
| D008670 | Metals |
| D001779 | Blood Coagulation Factors |
| D001685 | Biological Factors |
Not provided
Not provided